BSE Live
Nov 21, 16:01Prev. Close
2512.90
Open Price
2504.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 21, 15:46Prev. Close
2510.70
Open Price
2497.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2485.70 (4)
| Key Financial Ratios of Ajanta Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 53.60 | 43.97 | 53.26 | 57.59 | 47.23 | |
| Diluted EPS (Rs.) | 53.60 | 43.96 | 53.25 | 57.58 | 47.23 | |
| Cash EPS (Rs.) | 64.24 | 52.34 | 59.72 | 64.22 | 52.01 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 296.34 | 256.01 | 230.79 | 177.24 | 134.64 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 296.34 | 256.01 | 230.79 | 177.24 | 134.64 | |
| Revenue from Operations/Share (Rs.) | 295.08 | 234.36 | 240.33 | 224.22 | 197.78 | |
| PBDIT/Share (Rs.) | 88.43 | 66.99 | 77.17 | 80.36 | 68.76 | |
| PBIT/Share (Rs.) | 77.51 | 58.77 | 70.43 | 73.43 | 63.74 | |
| PBT/Share (Rs.) | 75.71 | 58.64 | 70.38 | 73.28 | 63.19 | |
| Net Profit/Share (Rs.) | 53.33 | 44.12 | 52.98 | 57.30 | 46.99 | |
| NP After MI And SOA / Share (Rs.) | 53.33 | 44.12 | 52.98 | 57.30 | 46.99 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 29.96 | 28.58 | 32.10 | 35.83 | 34.76 | |
| PBIT Margin (%) | 26.26 | 25.07 | 29.30 | 32.75 | 32.22 | |
| PBT Margin (%) | 25.65 | 25.02 | 29.28 | 32.68 | 31.94 | |
| Net Profit Margin (%) | 18.07 | 18.82 | 22.04 | 25.55 | 23.75 | |
| NP After MI And SOA Margin (%) | 18.07 | 18.82 | 22.04 | 25.55 | 23.75 | |
| Return on Networth/Equity (%) | 17.99 | 17.23 | 22.95 | 32.32 | 34.89 | |
| Return on Capital Employed (%) | 25.06 | 22.23 | 29.62 | 40.56 | 33.84 | |
| Return on Assets (%) | 14.09 | 14.35 | 19.13 | 27.43 | 27.93 | |
| Total Debt/Equity (X) | 0.02 | 0.02 | 0.00 | 0.00 | 0.05 | |
| Asset Turnover Ratio (%) | 77.97 | 76.23 | 86.81 | 107.33 | 117.56 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.71 | 3.13 | 3.54 | 3.45 | 2.94 | |
| Quick Ratio (X) | 1.89 | 1.97 | 2.52 | 2.59 | 2.15 | |
| Inventory Turnover Ratio (X) | 5.22 | 4.72 | 6.06 | 9.40 | 8.55 | |
| Dividend Payout Ratio (NP) (%) | 24.25 | 20.47 | 0.00 | 22.57 | 29.64 | |
| Dividend Payout Ratio (CP) (%) | 20.13 | 17.25 | 0.00 | 20.14 | 26.78 | |
| Earnings Retention Ratio (%) | 75.75 | 79.53 | 0.00 | 77.43 | 70.36 | |
| Cash Earnings Retention Ratio (%) | 79.87 | 82.75 | 0.00 | 79.86 | 73.22 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 57.08 | 444.34 | 1,519.41 | 477.60 | 115.29 | |
| Interest Coverage Ratios (Post Tax) (%) | 57.08 | 444.34 | 1,519.41 | 477.60 | 115.29 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 11,819.91 | 8,970.10 | 12,342.22 | 15,500.94 | 12,493.62 | |
| EV/Net Operating Revenue (X) | 4.57 | 4.36 | 5.81 | 7.82 | 7.14 | |
| EV/EBITDA (X) | 15.24 | 15.27 | 18.08 | 21.81 | 20.54 | |
| MarketCap/Net Operating Revenue (X) | 4.63 | 4.40 | 5.85 | 7.85 | 7.13 | |
| Retention Ratios (%) | 75.74 | 79.52 | 0.00 | 77.42 | 70.35 | |
| Price/BV (X) | 4.61 | 4.02 | 6.09 | 9.93 | 10.48 | |
| Price/Net Operating Revenue | 4.63 | 4.40 | 5.85 | 7.85 | 7.13 | |
| Earnings Yield | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 |
11.11.2025
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
10.11.2025
Ajanta Pharma Standalone September 2025 Net Sales at Rs 1,220.24 crore, up 8.09% Y-o-Y
04.11.2025
Ajanta Pharma Consolidated September 2025 Net Sales at Rs 1,353.73 crore, up 14.08% Y-o-Y
29.07.2025
Ajanta Pharma Consolidated June 2025 Net Sales at Rs 1,302.65 crore, up 13.78% Y-o-Y
29.07.2025
Ajanta Pharma Standalone June 2025 Net Sales at Rs 1,208.56 crore, up 12.19% Y-o-Y
12.07.2023
Ajanta Pharma Q1 PAT seen up 9.1% YoY to Rs 190.5 cr: Nirmal Bang
13.07.2022
Ajanta Pharma Q1 PAT may dip 12.7% YoY to Rs 151.6 cr: ICICI Direct
11.01.2019
Ajanta Pharma Q3 PAT may dip 35.1% YoY to Rs. 95.8 cr: ICICI Direct
12.10.2018
Ajanta Pharma Q2 PAT may dip 16.5% YoY to Rs. 110.1 cr: ICICI Direct